Notably, TP53 mutations have been associated with multiple cancers [43] and ZFHX4 has been recently found to involve in ovarian cancer [44], esophageal squamous cell carcinoma [45], breast cancer [46], and glioblastoma [47]. This evidence concerns the gene ZFHX4 and breast carcinoma.